New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Shape
Acurx Pharmaceuticals, Inc.
ACXP
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

15M

Biotechnology

Next Earning date - 17 Mar 2025

15M

Biotechnology

Next Earning date - 17 Mar 2025

0.89USD
Shape0.05 ( 5.94%)
Market Closed (as of Jan 03, 21:00 EDT)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

-13%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

83%

Quote Panel

Shape
Updated January 5, 2025
1W 4.33 % 1M 18.65 % 3M -58.02 % 1Y -78.30 %

Key Metrics

Shape
  • Market Cap

    15.03M


  • Shares Outstanding

    16.89M


  • Share in Float

    14.49M


  • Dividende

    0


  • Earning Date

    17 Mar 2025


  • Price Target

    0.8899


  • Average Volume

    131596


  • Beta

    -1.722


  • Range

    0.72-5.28


  • Industry

    Biotechnology


  • Website

    https://www.acurxpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

5.47x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-1.1

EPS

How ACXP compares to sector?

P/E Ratio

Relative Strength

Shape

ACXP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10M

ShapeNaN%

2025-Revenue

$1.43

Shape-741%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.28
vs -0.23

Q1.23

arrow
arrow

N/A

-0.25
vs -0.26

Q2.23

arrow
arrow

N/A

-0.28
vs -0.26

Q3.23

arrow
arrow

N/A

-0.24
vs -0.32

Q4.23

arrow
arrow

N/A

-0.38
vs -0.28

Q1.24

arrow
arrow

N/A

-0.28
vs -0.25

Q2.24

arrow
arrow

N/A

-0.26
vs -0.28

Q3.24

arrow
arrow

+100%

NA
vs -0.24

Q4.24

arrow
arrow

N/A

-0.17
vs -0.38

Q1.25

arrow
arrow

N/A

-0.38
vs -0.28

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+28%

0.28
vs -0.36

Q1.23

arrow
arrow

-55%

-0.55
vs 0.28

Q2.23

arrow
arrow

-55%

-0.55
vs -0.55

Q3.23

arrow
arrow

-79%

-0.79
vs -0.55

Q4.23

arrow
arrow

-110%

-1.10
vs -0.79

Q1.24

arrow
arrow

-73%

-0.73
vs -1.10

Q2.24

arrow
arrow

-120%

-1.20
vs -0.73

Q3.24

arrow
arrow

-105916%

-1059.16
vs -1.20

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

14

14
vs 12

17%

Q1.23

arrow
arrow

12

12
vs 14

-14%

Q2.23

arrow
arrow

12

12
vs 12

NA

Q3.23

arrow
arrow

17

17
vs 12

42%

Q4.23

arrow
arrow

25

25
vs 17

47%

Q1.24

arrow
arrow

27

27
vs 25

8%

Q2.24

arrow
arrow

26

26
vs 27

-4%

Q3.24

arrow
arrow

23

23
vs 26

-12%

Earnings Growth

Latest News